Sino-Health (Hangzhou) Biopharmaceutical

Sino-Health (Hangzhou) Biopharmaceutical is a biotechnology company focused on the research and development of exosome-based therapeutics and advanced cell therapies. Based in Hangzhou, China, the company utilizes a proprietary platform to engineer exosomes for the targeted delivery of various payloads, including proteins and nucleic acids. Their primary therapeutic focus areas include oncology, where they aim to improve the precision of cancer treatments, and inflammatory diseases. The company is part of the growing regenerative medicine ecosystem in the Qiantang District, collaborating with academic institutions to advance its early-stage pipeline. By leveraging the unique properties of exosomes as natural nanocarriers, Sino-Health seeks to develop next-generation biologics with enhanced safety and efficacy profiles.